Via de voorbeelden van menselijke vertaling trachten te leren vertalen.
Van professionele vertalers, bedrijven, webpagina's en gratis beschikbare vertaalbronnen.
waldenström risaglóbúlínblæði (wm)
waldenström’s macroglobulinaemia
Laatste Update: 2017-04-26
Gebruiksfrequentie: 1
Kwaliteit:
breyting á skömmtum cll/wm eftir bata
cll/wm dose modification after recovery
Laatste Update: 2017-04-26
Gebruiksfrequentie: 1
Kwaliteit:
eitilfrumnafjölgun kom ekki fram hjá sjúklingum með wm sem fengu meðferð með imbruvica.
lymphocytosis was not observed in patients with wm treated with imbruvica.
Laatste Update: 2017-04-26
Gebruiksfrequentie: 1
Kwaliteit:
langvinnt eitilfrumuhvítblæði (cll) og waldenström risaglóbúlínblæði (wm)
chronic lymphocytic leukaemia and waldenström’s macroglobulinaemia
Laatste Update: 2017-04-26
Gebruiksfrequentie: 1
Kwaliteit:
ráðlagður skammtur við meðferð á wm er 420 mg (þrjú hylki) einu sinni á sólarhring.
the recommended dose for the treatment of wm is 420 mg (three capsules) once daily.
Laatste Update: 2017-04-26
Gebruiksfrequentie: 1
Kwaliteit:
sjúklingar í meðferð við mcl í klínískum rannsóknum fengu 560 mg af imbruvica einu sinni á sólarhring og sjúklingar í meðferð við cll eða wm í klínískum rannsóknum fengu 420 mg af imbruvica einu sinni á sólarhring.
patients treated for mcl in clinical studies received imbruvica at 560 mg once daily and patients treated for cll or wm in clinical studies received imbruvica at 420 mg once daily.
Laatste Update: 2017-04-26
Gebruiksfrequentie: 1
Kwaliteit:
tafla 8: heildarsvörunartíðni (orr) og lengd svörunar (dor) hjá sjúklingum með wm
table 8: overall response rate (orr) and duration of response (dor) in patients with wm
Laatste Update: 2017-04-26
Gebruiksfrequentie: 1
Kwaliteit:
imbruvica, sem einlyfjameðferð, er ætlað til meðferðar hjá fullorðnum sjúklingum með waldenström risaglóbúlínblæði (waldenström‘s macroglobulinaemia (wm)) sem hafa fengið a.m.k. eina meðferð áður, eða sem fyrsta meðferð hjá sjúklingum þar sem lyfja-ónæmismeðferð er óviðeigandi.
imbruvica as a single agent is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy.
Laatste Update: 2017-04-26
Gebruiksfrequentie: 1
Kwaliteit: